Market Outlook
The global Liquid Biopsy Products market size was valued at USD 1763.6 million in 2022 and is forecast to a readjusted size of USD 8132.7 million by 2029 with a CAGR of 24.4% during review period.
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
This report is a detailed and comprehensive analysis for global Liquid Biopsy Products market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liquid Biopsy Products market size and forecasts, in consumption value ($ Million), 2018-2029
Global Liquid Biopsy Products market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Liquid Biopsy Products market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Liquid Biopsy Products market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liquid Biopsy Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liquid Biopsy Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Segmentation By Type
CTCs
ctDNA
Exosomes
Segmentation By Application
Blood Sample
Urine Sample
Other Bio Fluids
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Liquid Biopsy Products Market in 2025?
The primary strength is the non-invasive nature of liquid biopsy, allowing for early detection of cancer and other diseases without the need for traditional biopsies. This enhances patient comfort and can lead to earlier intervention, which improves prognosis. Additionally, technological advancements are increasing accuracy and reliability, making liquid biopsy an attractive diagnostic tool.
What are the weaknesses of the Liquid Biopsy Products Market in 2025?
One major weakness is the high cost of liquid biopsy tests, which could limit access, particularly in lower-income regions. Furthermore, while the technology is promising, it still lacks widespread clinical validation for all types of cancer, and there are challenges in standardizing the procedures across different healthcare settings.
What opportunities exist for the Liquid Biopsy Products Market in 2025?
The market has significant opportunities in the areas of personalized medicine and precision oncology. As the demand for more targeted therapies grows, liquid biopsy products offer the potential for real-time monitoring of treatment efficacy. Additionally, expanding research and development could unlock new applications in detecting a wider range of diseases beyond cancer.
What are the threats to the Liquid Biopsy Products Market in 2025?
Regulatory hurdles and slow adoption in some regions could hinder market growth. Competition from other diagnostic technologies, like tissue biopsies or imaging techniques, might also pose a threat. Moreover, ethical concerns about genetic testing and patient privacy could lead to increased scrutiny, potentially impacting market growth.
Market PESTEL Analysis
What political factors affect the Liquid Biopsy Products Market in 2025?
Government policies and regulations regarding healthcare, particularly concerning the approval of medical technologies, significantly impact the market. Changes in reimbursement policies or healthcare budgets can either promote or restrict access to liquid biopsy tests. Additionally, government funding for cancer research can drive innovation and market growth.
How do economic factors influence the Liquid Biopsy Products Market in 2025?
The affordability of liquid biopsy tests is a key economic factor. High prices can limit access to these products, particularly in lower-income regions. Economic growth and the rising demand for personalized medicine are driving investment in liquid biopsy technologies. However, healthcare budget constraints in some countries may hinder broader adoption.
What social factors impact the Liquid Biopsy Products Market in 2025?
There is a growing awareness and acceptance of non-invasive diagnostic methods, which is contributing to the increasing demand for liquid biopsy products. Patients are becoming more informed and prefer less invasive procedures. However, there may still be hesitancy in adopting new technologies in some communities, particularly where traditional diagnostic methods are more established.
How do technological factors affect the Liquid Biopsy Products Market in 2025?
Advances in genomics, sequencing technology, and bioinformatics are critical drivers for the development of liquid biopsy products. As these technologies continue to evolve, they enable more accurate, rapid, and cost-effective testing. Innovation in AI and machine learning also holds the potential to further enhance diagnostic capabilities and interpretation of results.
What environmental factors influence the Liquid Biopsy Products Market in 2025?
Environmental factors like the increasing focus on sustainable healthcare solutions are encouraging the development of less resource-intensive diagnostic methods like liquid biopsies. Additionally, concerns about environmental impacts may encourage the healthcare industry to adopt more eco-friendly practices, such as minimizing the use of materials needed for traditional biopsy procedures.
What legal factors impact the Liquid Biopsy Products Market in 2025?
Legal considerations around data privacy and patient consent, especially regarding genetic information, are significant in the liquid biopsy market. Compliance with healthcare regulations and the need for robust intellectual property protections can affect innovation and market entry. Additionally, regulations on diagnostic testing approval and quality standards are critical for market expansion.
Market SIPOC Analysis
Who are the suppliers in the Liquid Biopsy Products Market in 2025?
Suppliers include manufacturers of diagnostic reagents, sequencing equipment, laboratory instruments, and bioinformatics software. Additionally, raw material suppliers for creating testing kits and consumables play a critical role in ensuring the availability and quality of the products.
Who are the inputs in the Liquid Biopsy Products Market in 2025?
The inputs consist of advanced genomic sequencing technologies, blood or other bodily fluids for analysis, reagents, and software for data analysis. Research data, clinical trial results, and regulatory approvals also serve as vital inputs for product development and market growth.
Who are the process owners in the Liquid Biopsy Products Market in 2025?
Process owners include biotechnology companies, diagnostic laboratories, and healthcare providers. They are responsible for conducting research, developing, validating, and implementing liquid biopsy tests in clinical settings. Regulatory agencies also play a role in overseeing processes to ensure compliance with standards and safety regulations.
Who are the outputs in the Liquid Biopsy Products Market in 2025?
Outputs include liquid biopsy diagnostic kits, testing services, and genetic analysis reports for clinicians and patients. These products and services enable early detection, monitoring, and treatment planning for cancers and other diseases, providing critical insights for personalized healthcare.
Who are the customers in the Liquid Biopsy Products Market in 2025?
Customers are healthcare providers such as hospitals, clinics, and diagnostic centers that utilize liquid biopsy tests. Patients seeking non-invasive diagnostic options for cancer or other conditions also represent a key customer group. Pharmaceutical companies may also be customers, using liquid biopsy technologies for clinical trials and research.
Market Porter's Five Forces
What is the threat of new entrants in the Liquid Biopsy Products Market in 2025?
The threat of new entrants is moderate. While the potential for innovation and profit is high, the market is highly regulated, requiring significant investment in research, development, and regulatory approvals. Additionally, established players already have strong brand recognition and partnerships with healthcare providers, which can create barriers to entry.
What is the bargaining power of suppliers in the Liquid Biopsy Products Market in 2025?
The bargaining power of suppliers is relatively high. Suppliers of key components such as genomic sequencing technologies, reagents, and laboratory equipment control the quality and availability of essential materials. The specialized nature of these inputs gives suppliers significant leverage over pricing and availability.
What is the bargaining power of buyers in the Liquid Biopsy Products Market in 2025?
The bargaining power of buyers is moderate to high. As healthcare providers and patients seek advanced, non-invasive diagnostic methods, there is increasing demand for liquid biopsy products. However, buyers are somewhat limited by the high cost of tests and the limited number of suppliers, giving them less power to negotiate prices.
What is the threat of substitute products in the Liquid Biopsy Products Market in 2025?
The threat of substitutes is moderate. Traditional biopsy methods, such as tissue biopsies and imaging technologies, still hold significant value in certain clinical situations. However, as liquid biopsy technologies continue to improve in accuracy and reliability, they may gradually replace traditional methods in many cases, lowering the threat from substitutes.
What is the intensity of competitive rivalry in the Liquid Biopsy Products Market in 2025?
The intensity of competitive rivalry is high. The market for liquid biopsy products is growing rapidly, attracting numerous companies offering innovative solutions. Established players are competing with new entrants to capture market share, and there is constant pressure to improve the technology, reduce costs, and expand into new markets. This leads to fierce competition among key industry players.
Market Upstream Analysis
What are the key raw materials required for the Liquid Biopsy Products Market in 2025?
The key raw materials include genomic reagents, chemicals for blood sample preservation, and consumables like test kits, tubes, and vials. Additionally, high-quality sequencing equipment and laboratory instruments are essential for processing and analyzing the samples.
Who are the main suppliers involved in the upstream process of Liquid Biopsy Products?
The main suppliers are companies that produce genomic sequencing technologies, such as Illumina and Thermo Fisher. Additionally, suppliers of reagents, chemicals, and diagnostic equipment used in the preparation and analysis of liquid biopsy tests play a critical role in the upstream process.
What are the technological requirements in the upstream process for Liquid Biopsy Products?
Technological requirements include advanced sequencing platforms, data analysis software, and bioinformatics tools for interpreting genetic data. High-throughput sequencing technologies are particularly critical, along with innovations in liquid biopsy collection and processing equipment to ensure accurate and reliable results.
What regulatory and compliance challenges exist in the upstream process of Liquid Biopsy Products?
Regulatory challenges involve compliance with health authorities like the FDA and EMA for approval of liquid biopsy tests and associated equipment. Manufacturers must adhere to strict guidelines for medical devices, laboratory practices, and patient data privacy, which can impact the time and cost to bring products to market.
How do research and development efforts affect the upstream process of Liquid Biopsy Products?
R&D is crucial for advancing the sensitivity and specificity of liquid biopsy tests. Investments in innovation help develop new testing platforms, refine biomarker identification, and enhance data analysis algorithms, thereby improving the overall performance of liquid biopsy products and expanding their clinical applications.
Market Midstream Analysis
What are the key activities in the midstream process of the Liquid Biopsy Products Market in 2025?
The key activities in the midstream process include the preparation and analysis of liquid biopsy samples, such as blood or other bodily fluids, followed by genomic sequencing. This also involves the data processing and interpretation phases, where bioinformatics tools are used to extract meaningful insights for diagnosis and treatment planning.
What role do diagnostic labs play in the midstream process of Liquid Biopsy Products?
Diagnostic labs are central to the midstream process. They receive liquid biopsy samples, conduct tests using advanced sequencing technology, and analyze the genetic data to produce diagnostic results. Their role is vital in ensuring the accuracy and reliability of results before they are provided to healthcare providers.
How do partnerships and collaborations impact the midstream process of Liquid Biopsy Products?
Partnerships between technology providers, such as sequencing equipment manufacturers, and diagnostic service providers enhance the midstream process. These collaborations ensure the integration of cutting-edge technology into diagnostic workflows, allowing for faster, more accurate results. They also help expand market access and facilitate the development of standardized protocols for liquid biopsy tests.
What are the challenges in the midstream process of Liquid Biopsy Products?
Challenges include the high complexity and cost of genomic sequencing, the need for accurate sample collection and processing, and ensuring data consistency across different platforms. Additionally, there are logistical challenges in ensuring timely delivery and quality control of samples and results, which can impact patient outcomes.
How does data analysis and interpretation affect the midstream process of Liquid Biopsy Products?
Data analysis and interpretation are crucial in the midstream process, as the ability to accurately identify genetic mutations or biomarkers from sequencing data directly impacts the diagnosis. Advanced bioinformatics and AI tools are necessary for processing large datasets, but the accuracy and speed of these tools are still evolving and could affect diagnostic reliability.
Market Downstream Analysis
What are the key activities in the downstream process of the Liquid Biopsy Products Market in 2025?
The key activities in the downstream process include the distribution of liquid biopsy tests to healthcare providers, such as hospitals, clinics, and specialized cancer centers. It also involves providing results to clinicians, who use the data to guide patient treatment plans. Additionally, it encompasses post-test support, including consultations and follow-up diagnostics.
How do healthcare providers influence the downstream process of Liquid Biopsy Products?
Healthcare providers are critical in the downstream process, as they are the end-users of liquid biopsy tests. They interpret the results to make informed decisions about treatment options. The adoption rate among healthcare providers can influence the market's success, as it determines how widely liquid biopsy products are implemented in clinical practice.
What is the role of patient access and education in the downstream process of Liquid Biopsy Products?
Patient access and education play a crucial role in the downstream process. For liquid biopsy tests to be effective, patients need to understand the procedure, benefits, and potential risks. Proper education ensures higher acceptance rates and helps patients make informed decisions about their treatment options, thereby driving demand for these products.
What challenges exist in the downstream process of Liquid Biopsy Products?
Challenges include navigating reimbursement issues, as liquid biopsy tests are often expensive and may not be covered by all insurance providers. Additionally, there may be delays in integrating liquid biopsy into routine clinical practice due to resistance to adopting new technologies or lack of awareness. Ensuring widespread access and affordability remains a key hurdle.
How does market expansion influence the downstream process of Liquid Biopsy Products?
Market expansion, particularly into emerging markets, can increase the accessibility of liquid biopsy products. As more regions adopt liquid biopsy technologies, demand for the tests will grow, allowing for better diagnostic capabilities and more personalized treatments globally. This growth can also drive economies of scale, potentially lowering costs and improving market penetration.
Chapter 1, to describe Liquid Biopsy Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy Products, with revenue, gross margin and global market share of Liquid Biopsy Products from 2018 to 2023.
Chapter 3, the Liquid Biopsy Products competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Liquid Biopsy Products market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy Products.
Chapter 13, to describe Liquid Biopsy Products research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Liquid Biopsy Products
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy Products by Type
1.3.1 Overview: Global Liquid Biopsy Products Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Liquid Biopsy Products Consumption Value Market Share by Type in 2022
1.3.3 CTCs
1.3.4 ctDNA
1.3.5 Exosomes
1.4 Global Liquid Biopsy Products Market by Application
1.4.1 Overview: Global Liquid Biopsy Products Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Blood Sample
1.4.3 Urine Sample
1.4.4 Other Bio Fluids
1.5 Global Liquid Biopsy Products Market Size & Forecast
1.6 Global Liquid Biopsy Products Market Size and Forecast by Region
1.6.1 Global Liquid Biopsy Products Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Liquid Biopsy Products Market Size by Region, (2018-2029)
1.6.3 North America Liquid Biopsy Products Market Size and Prospect (2018-2029)
1.6.4 Europe Liquid Biopsy Products Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Liquid Biopsy Products Market Size and Prospect (2018-2029)
1.6.6 South America Liquid Biopsy Products Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Liquid Biopsy Products Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 RainDanceTechnologies
2.1.1 RainDanceTechnologies Details
2.1.2 RainDanceTechnologies Major Business
2.1.3 RainDanceTechnologies Liquid Biopsy Products Product and Solutions
2.1.4 RainDanceTechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 RainDanceTechnologies Recent Developments and Future Plans
2.2 Biocartis
2.2.1 Biocartis Details
2.2.2 Biocartis Major Business
2.2.3 Biocartis Liquid Biopsy Products Product and Solutions
2.2.4 Biocartis Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Biocartis Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Liquid Biopsy Products Product and Solutions
2.3.4 Qiagen Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Guardant Health
2.4.1 Guardant Health Details
2.4.2 Guardant Health Major Business
2.4.3 Guardant Health Liquid Biopsy Products Product and Solutions
2.4.4 Guardant Health Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Guardant Health Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Liquid Biopsy Products Product and Solutions
2.5.4 MDxHealth Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Pathway Genomics
2.6.1 Pathway Genomics Details
2.6.2 Pathway Genomics Major Business
2.6.3 Pathway Genomics Liquid Biopsy Products Product and Solutions
2.6.4 Pathway Genomics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pathway Genomics Recent Developments and Future Plans
2.7 NeoGenomics Laboraories
2.7.1 NeoGenomics Laboraories Details
2.7.2 NeoGenomics Laboraories Major Business
2.7.3 NeoGenomics Laboraories Liquid Biopsy Products Product and Solutions
2.7.4 NeoGenomics Laboraories Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.8 Sysmex Inostics
2.8.1 Sysmex Inostics Details
2.8.2 Sysmex Inostics Major Business
2.8.3 Sysmex Inostics Liquid Biopsy Products Product and Solutions
2.8.4 Sysmex Inostics Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sysmex Inostics Recent Developments and Future Plans
2.9 Cynvenio
2.9.1 Cynvenio Details
2.9.2 Cynvenio Major Business
2.9.3 Cynvenio Liquid Biopsy Products Product and Solutions
2.9.4 Cynvenio Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cynvenio Recent Developments and Future Plans
2.10 Menarini Silicon Biosystems
2.10.1 Menarini Silicon Biosystems Details
2.10.2 Menarini Silicon Biosystems Major Business
2.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Product and Solutions
2.10.4 Menarini Silicon Biosystems Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.11 Adaptive Biotechnologies
2.11.1 Adaptive Biotechnologies Details
2.11.2 Adaptive Biotechnologies Major Business
2.11.3 Adaptive Biotechnologies Liquid Biopsy Products Product and Solutions
2.11.4 Adaptive Biotechnologies Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business
2.12.3 Biocept Liquid Biopsy Products Product and Solutions
2.12.4 Biocept Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biocept Recent Developments and Future Plans
2.13 Angle plc
2.13.1 Angle plc Details
2.13.2 Angle plc Major Business
2.13.3 Angle plc Liquid Biopsy Products Product and Solutions
2.13.4 Angle plc Liquid Biopsy Products Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Angle plc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Liquid Biopsy Products Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Liquid Biopsy Products by Company Revenue
3.2.2 Top 3 Liquid Biopsy Products Players Market Share in 2022
3.2.3 Top 6 Liquid Biopsy Products Players Market Share in 2022
3.3 Liquid Biopsy Products Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Products Market: Region Footprint
3.3.2 Liquid Biopsy Products Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Products Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Liquid Biopsy Products Consumption Value and Market Share by Type (2018-2023)
4.2 Global Liquid Biopsy Products Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Liquid Biopsy Products Consumption Value Market Share by Application (2018-2023)
5.2 Global Liquid Biopsy Products Market Forecast by Application (2024-2029)
6 North America
6.1 North America Liquid Biopsy Products Consumption Value by Type (2018-2029)
6.2 North America Liquid Biopsy Products Consumption Value by Application (2018-2029)
6.3 North America Liquid Biopsy Products Market Size by Country
6.3.1 North America Liquid Biopsy Products Consumption Value by Country (2018-2029)
6.3.2 United States Liquid Biopsy Products Market Size and Forecast (2018-2029)
6.3.3 Canada Liquid Biopsy Products Market Size and Forecast (2018-2029)
6.3.4 Mexico Liquid Biopsy Products Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Liquid Biopsy Products Consumption Value by Type (2018-2029)
7.2 Europe Liquid Biopsy Products Consumption Value by Application (2018-2029)
7.3 Europe Liquid Biopsy Products Market Size by Country
7.3.1 Europe Liquid Biopsy Products Consumption Value by Country (2018-2029)
7.3.2 Germany Liquid Biopsy Products Market Size and Forecast (2018-2029)
7.3.3 France Liquid Biopsy Products Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Liquid Biopsy Products Market Size and Forecast (2018-2029)
7.3.5 Russia Liquid Biopsy Products Market Size and Forecast (2018-2029)
7.3.6 Italy Liquid Biopsy Products Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Products Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Liquid Biopsy Products Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Liquid Biopsy Products Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Products Consumption Value by Region (2018-2029)
8.3.2 China Liquid Biopsy Products Market Size and Forecast (2018-2029)
8.3.3 Japan Liquid Biopsy Products Market Size and Forecast (2018-2029)
8.3.4 South Korea Liquid Biopsy Products Market Size and Forecast (2018-2029)
8.3.5 India Liquid Biopsy Products Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Liquid Biopsy Products Market Size and Forecast (2018-2029)
8.3.7 Australia Liquid Biopsy Products Market Size and Forecast (2018-2029)
9 South America
9.1 South America Liquid Biopsy Products Consumption Value by Type (2018-2029)
9.2 South America Liquid Biopsy Products Consumption Value by Application (2018-2029)
9.3 South America Liquid Biopsy Products Market Size by Country
9.3.1 South America Liquid Biopsy Products Consumption Value by Country (2018-2029)
9.3.2 Brazil Liquid Biopsy Products Market Size and Forecast (2018-2029)
9.3.3 Argentina Liquid Biopsy Products Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Products Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Liquid Biopsy Products Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Liquid Biopsy Products Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Products Consumption Value by Country (2018-2029)
10.3.2 Turkey Liquid Biopsy Products Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Liquid Biopsy Products Market Size and Forecast (2018-2029)
10.3.4 UAE Liquid Biopsy Products Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Liquid Biopsy Products Market Drivers
11.2 Liquid Biopsy Products Market Restraints
11.3 Liquid Biopsy Products Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Liquid Biopsy Products Industry Chain
12.2 Liquid Biopsy Products Upstream Analysis
12.3 Liquid Biopsy Products Midstream Analysis
12.4 Liquid Biopsy Products Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Liquid Biopsy Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liquid Biopsy Products Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Liquid Biopsy Products Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Liquid Biopsy Products Consumption Value by Region (2024-2029) & (USD Million)
Table 5. RainDanceTechnologies Company Information, Head Office, and Major Competitors
Table 6. RainDanceTechnologies Major Business
Table 7. RainDanceTechnologies Liquid Biopsy Products Product and Solutions
Table 8. RainDanceTechnologies Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. RainDanceTechnologies Recent Developments and Future Plans
Table 10. Biocartis Company Information, Head Office, and Major Competitors
Table 11. Biocartis Major Business
Table 12. Biocartis Liquid Biopsy Products Product and Solutions
Table 13. Biocartis Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Biocartis Recent Developments and Future Plans
Table 15. Qiagen Company Information, Head Office, and Major Competitors
Table 16. Qiagen Major Business
Table 17. Qiagen Liquid Biopsy Products Product and Solutions
Table 18. Qiagen Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Qiagen Recent Developments and Future Plans
Table 20. Guardant Health Company Information, Head Office, and Major Competitors
Table 21. Guardant Health Major Business
Table 22. Guardant Health Liquid Biopsy Products Product and Solutions
Table 23. Guardant Health Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Guardant Health Recent Developments and Future Plans
Table 25. MDxHealth Company Information, Head Office, and Major Competitors
Table 26. MDxHealth Major Business
Table 27. MDxHealth Liquid Biopsy Products Product and Solutions
Table 28. MDxHealth Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. MDxHealth Recent Developments and Future Plans
Table 30. Pathway Genomics Company Information, Head Office, and Major Competitors
Table 31. Pathway Genomics Major Business
Table 32. Pathway Genomics Liquid Biopsy Products Product and Solutions
Table 33. Pathway Genomics Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pathway Genomics Recent Developments and Future Plans
Table 35. NeoGenomics Laboraories Company Information, Head Office, and Major Competitors
Table 36. NeoGenomics Laboraories Major Business
Table 37. NeoGenomics Laboraories Liquid Biopsy Products Product and Solutions
Table 38. NeoGenomics Laboraories Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NeoGenomics Laboraories Recent Developments and Future Plans
Table 40. Sysmex Inostics Company Information, Head Office, and Major Competitors
Table 41. Sysmex Inostics Major Business
Table 42. Sysmex Inostics Liquid Biopsy Products Product and Solutions
Table 43. Sysmex Inostics Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sysmex Inostics Recent Developments and Future Plans
Table 45. Cynvenio Company Information, Head Office, and Major Competitors
Table 46. Cynvenio Major Business
Table 47. Cynvenio Liquid Biopsy Products Product and Solutions
Table 48. Cynvenio Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Cynvenio Recent Developments and Future Plans
Table 50. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 51. Menarini Silicon Biosystems Major Business
Table 52. Menarini Silicon Biosystems Liquid Biopsy Products Product and Solutions
Table 53. Menarini Silicon Biosystems Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 55. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
Table 56. Adaptive Biotechnologies Major Business
Table 57. Adaptive Biotechnologies Liquid Biopsy Products Product and Solutions
Table 58. Adaptive Biotechnologies Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Adaptive Biotechnologies Recent Developments and Future Plans
Table 60. Biocept Company Information, Head Office, and Major Competitors
Table 61. Biocept Major Business
Table 62. Biocept Liquid Biopsy Products Product and Solutions
Table 63. Biocept Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Biocept Recent Developments and Future Plans
Table 65. Angle plc Company Information, Head Office, and Major Competitors
Table 66. Angle plc Major Business
Table 67. Angle plc Liquid Biopsy Products Product and Solutions
Table 68. Angle plc Liquid Biopsy Products Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Angle plc Recent Developments and Future Plans
Table 70. Global Liquid Biopsy Products Revenue (USD Million) by Players (2018-2023)
Table 71. Global Liquid Biopsy Products Revenue Share by Players (2018-2023)
Table 72. Breakdown of Liquid Biopsy Products by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Liquid Biopsy Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Liquid Biopsy Products Players
Table 75. Liquid Biopsy Products Market: Company Product Type Footprint
Table 76. Liquid Biopsy Products Market: Company Product Application Footprint
Table 77. Liquid Biopsy Products New Market Entrants and Barriers to Market Entry
Table 78. Liquid Biopsy Products Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Liquid Biopsy Products Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Liquid Biopsy Products Consumption Value Share by Type (2018-2023)
Table 81. Global Liquid Biopsy Products Consumption Value Forecast by Type (2024-2029)
Table 82. Global Liquid Biopsy Products Consumption Value by Application (2018-2023)
Table 83. Global Liquid Biopsy Products Consumption Value Forecast by Application (2024-2029)
Table 84. North America Liquid Biopsy Products Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Liquid Biopsy Products Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Liquid Biopsy Products Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Liquid Biopsy Products Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Liquid Biopsy Products Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Liquid Biopsy Products Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Liquid Biopsy Products Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Liquid Biopsy Products Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Liquid Biopsy Products Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Liquid Biopsy Products Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Liquid Biopsy Products Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Liquid Biopsy Products Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Liquid Biopsy Products Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Liquid Biopsy Products Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Liquid Biopsy Products Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Liquid Biopsy Products Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Liquid Biopsy Products Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Liquid Biopsy Products Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Liquid Biopsy Products Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Liquid Biopsy Products Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Liquid Biopsy Products Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Liquid Biopsy Products Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Liquid Biopsy Products Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Liquid Biopsy Products Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Liquid Biopsy Products Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Liquid Biopsy Products Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Liquid Biopsy Products Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Liquid Biopsy Products Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Liquid Biopsy Products Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Liquid Biopsy Products Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Liquid Biopsy Products Raw Material
Table 115. Key Suppliers of Liquid Biopsy Products Raw Materials
List of Figures
Figure 1. Liquid Biopsy Products Picture
Figure 2. Global Liquid Biopsy Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liquid Biopsy Products Consumption Value Market Share by Type in 2022
Figure 4. CTCs
Figure 5. ctDNA
Figure 6. Exosomes
Figure 7. Global Liquid Biopsy Products Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Liquid Biopsy Products Consumption Value Market Share by Application in 2022
Figure 9. Blood Sample Picture
Figure 10. Urine Sample Picture
Figure 11. Other Bio Fluids Picture
Figure 12. Global Liquid Biopsy Products Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Liquid Biopsy Products Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Liquid Biopsy Products Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Liquid Biopsy Products Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Liquid Biopsy Products Consumption Value Market Share by Region in 2022
Figure 17. North America Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Liquid Biopsy Products Revenue Share by Players in 2022
Figure 23. Liquid Biopsy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Liquid Biopsy Products Market Share in 2022
Figure 25. Global Top 6 Players Liquid Biopsy Products Market Share in 2022
Figure 26. Global Liquid Biopsy Products Consumption Value Share by Type (2018-2023)
Figure 27. Global Liquid Biopsy Products Market Share Forecast by Type (2024-2029)
Figure 28. Global Liquid Biopsy Products Consumption Value Share by Application (2018-2023)
Figure 29. Global Liquid Biopsy Products Market Share Forecast by Application (2024-2029)
Figure 30. North America Liquid Biopsy Products Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Liquid Biopsy Products Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Liquid Biopsy Products Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Liquid Biopsy Products Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Liquid Biopsy Products Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Liquid Biopsy Products Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 40. France Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Liquid Biopsy Products Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Liquid Biopsy Products Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Liquid Biopsy Products Consumption Value Market Share by Region (2018-2029)
Figure 47. China Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 50. India Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Liquid Biopsy Products Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Liquid Biopsy Products Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Liquid Biopsy Products Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Liquid Biopsy Products Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Liquid Biopsy Products Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Liquid Biopsy Products Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Liquid Biopsy Products Consumption Value (2018-2029) & (USD Million)
Figure 64. Liquid Biopsy Products Market Drivers
Figure 65. Liquid Biopsy Products Market Restraints
Figure 66. Liquid Biopsy Products Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Liquid Biopsy Products in 2022
Figure 69. Manufacturing Process Analysis of Liquid Biopsy Products
Figure 70. Liquid Biopsy Products Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
